Will the unclear path of biosimilar interchangeability become clearer? - CLASSICA - Regulatory and legal aspects of an AI-based medical device

CeBIL - Center for Advanced Studies in Bioscience Innovation Law

Will the unclear path of biosimilar interchangeability become clearer?

Press/Media: Press / Media

11/03/2022

References

Will the unclear path of biosimilar interchangeability become clearer?
Louise C. Druedahl
GABI (Generics And Biosimilars Initiative)
https://gabionline.net/es/biosimilares/investigacion/will-the-unclear-path-of-biosimilar-interchangeability-become-clearer

ID: 305171033